![Abnormal High-sensitivity C-reactive Protein is Associated with an Increased Risk of Cardiovascular Disease and Renal Dysfunction among Patients Diagnosed with Type 2 Diabetes Mellitus in Palestine | The Review of Diabetic Studies Abnormal High-sensitivity C-reactive Protein is Associated with an Increased Risk of Cardiovascular Disease and Renal Dysfunction among Patients Diagnosed with Type 2 Diabetes Mellitus in Palestine | The Review of Diabetic Studies](https://diabeticstudies.org/sites/default/files/styles/large/public/RevDiabeticStud-18-1-27.png?itok=j2_Kkfh2)
Abnormal High-sensitivity C-reactive Protein is Associated with an Increased Risk of Cardiovascular Disease and Renal Dysfunction among Patients Diagnosed with Type 2 Diabetes Mellitus in Palestine | The Review of Diabetic Studies
![Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease | Circulation Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease | Circulation](https://www.ahajournals.org/cms/asset/c40c0e56-79f0-4e2f-8f7a-61a4069eda11/hc0681276001.jpeg)
Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease | Circulation
Prediction of 72-hour mortality in patients with extremely high serum C-reactive protein levels using a novel weighted average of risk scores | PLOS ONE
![Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials - eClinicalMedicine Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials - eClinicalMedicine](https://www.thelancet.com/cms/attachment/7cd59dc5-edb8-4505-bcd7-abcf79f0f64b/gr1.jpg)
Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials - eClinicalMedicine
![The impact of C-reactive protein levels on headache frequency in the HUNT study 2006–2008 | BMC Neurology | Full Text The impact of C-reactive protein levels on headache frequency in the HUNT study 2006–2008 | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-019-1462-8/MediaObjects/12883_2019_1462_Fig1_HTML.png)
The impact of C-reactive protein levels on headache frequency in the HUNT study 2006–2008 | BMC Neurology | Full Text
![Abnormal High-sensitivity C-reactive Protein is Associated with an Increased Risk of Cardiovascular Disease and Renal Dysfunction among Patients Diagnosed with Type 2 Diabetes Mellitus in Palestine | The Review of Diabetic Studies Abnormal High-sensitivity C-reactive Protein is Associated with an Increased Risk of Cardiovascular Disease and Renal Dysfunction among Patients Diagnosed with Type 2 Diabetes Mellitus in Palestine | The Review of Diabetic Studies](https://diabeticstudies.org/sites/default/files/RevDiabeticStud-18-1-27.png)
Abnormal High-sensitivity C-reactive Protein is Associated with an Increased Risk of Cardiovascular Disease and Renal Dysfunction among Patients Diagnosed with Type 2 Diabetes Mellitus in Palestine | The Review of Diabetic Studies
![David Sinclair on Twitter: "A C-reactive protein level <1 mg/L signifies low heart disease risk. Analysis of randomized controlled trials found significant reductions in CRP levels (-0.34) in type 2 diabetics who David Sinclair on Twitter: "A C-reactive protein level <1 mg/L signifies low heart disease risk. Analysis of randomized controlled trials found significant reductions in CRP levels (-0.34) in type 2 diabetics who](https://pbs.twimg.com/media/ESxP1kEXgAIHWp-.jpg)
David Sinclair on Twitter: "A C-reactive protein level <1 mg/L signifies low heart disease risk. Analysis of randomized controlled trials found significant reductions in CRP levels (-0.34) in type 2 diabetics who
![PDF) C-reactive protein levels during a relapse of Crohn's disease are associated with the clinical course of the disease PDF) C-reactive protein levels during a relapse of Crohn's disease are associated with the clinical course of the disease](https://www.researchgate.net/profile/Matthijs-Schwartz/publication/5673237/figure/tbl1/AS:601658090340373@1520457875505/Subgroups-with-an-index-serum-C-reactive-protein-CRP-level-of-15-and-15-mg-L_Q320.jpg)
PDF) C-reactive protein levels during a relapse of Crohn's disease are associated with the clinical course of the disease
![Distribution of blood leukocyte count (109/L) and C-reactive protein... | Download Scientific Diagram Distribution of blood leukocyte count (109/L) and C-reactive protein... | Download Scientific Diagram](https://www.researchgate.net/publication/346369076/figure/fig2/AS:1022927642320896@1620896363329/Fig-2-Distribution-of-blood-leukocyte-count-109-L-and-C-reactive-protein-mg-L.png)
Distribution of blood leukocyte count (109/L) and C-reactive protein... | Download Scientific Diagram
![C-reactive protein (CRP) level (mg/L) and serum amyloid A (SAA) (mg/L)... | Download Scientific Diagram C-reactive protein (CRP) level (mg/L) and serum amyloid A (SAA) (mg/L)... | Download Scientific Diagram](https://www.researchgate.net/publication/315327773/figure/fig1/AS:614263383134252@1523463211976/C-reactive-protein-CRP-level-mg-L-and-serum-amyloid-A-SAA-mg-L-levels-before-and.png)
C-reactive protein (CRP) level (mg/L) and serum amyloid A (SAA) (mg/L)... | Download Scientific Diagram
![C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study | Gut C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study | Gut](https://gut.bmj.com/content/gutjnl/57/11/1518/F3.large.jpg)